Medical devics maker Boston Scientific Corp (BSX), Monday revealed the launch of its cardiac resynchronization therapy defibrillator, Cognis and implantable cardioverter defibrillator, Teligen in Japan to treat heart failure and sudden cardiac death.
Japanese Ministry of Health had approved Cognis and Teligen in August and, these devices had received reimbursement approval in September.
Cognis and Teligen are the world's smallest and thinnest high-energy devices and, these devices offer features based on substantial engineering advances, including extended battery longevity, self-correcting software and improved programming technology, the company said.
Commenting on the defibrillators Ken Stein, Associate Chief Medical Officer, Boston Scientific CRM said, "The significantly reduced size of these devices has been well received by physicians in the U.S. and Europe, resulting in more than 75,000 implants in less than two years."
"In the past, physicians often had to make trade-offs among device size, battery longevity and features when prescribing a high-energy device. These devices eliminate those trade-offs without compromising therapy options," Stein added.
SafetyCore hardware system which is offered in both the defibrillators provides life-saving shock therapy and basic pacing functionality in the unlikely event of a system error.
Further both the devices employ digital signal processors and are equipped with increased levels of digital memory, enabling more patient data to be captured and used by physicians.
BSX is currently trading at $8.28, up $0.20 or 2.48%, on the NYSE.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.